Active — Not RecruitingNot Applicable

Observatory to Assess the Yukon Choice PC & the Yukon Chrome PC Sirolimus Eluting Bioabsorbable Polymer Stents Systems

France2,722 participantsStarted 2019-04-17

Plain-language summary

The TRANSLUMINA GmbH YuChooSeR Observatory is a prospective, multicentric post-marketing observatory designed to evaluate large scale safety and reliability of the Yukon Choice PC and the Yukon Chrome PC stents systems use in routine, clinical practice. This based observatory will enroll 3000 patients to 30 sites in France.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Any patient suitable for implantation with a Yukon Choice PC or a Yukon Chrome PC stent according to current guidelines can be enrolled in this observatory * Patient must be over 18 years old. Exclusion Criteria: * Patient not able to understand the information given for collection, transfer and processing of personal data before participation, may not be enrolled in this observatory.

What they're measuring

The primary endpoint is Target Lesion Failure (TLF) rate at 12 months follow-up

Timeframe: 12 months follow-up

Trial details

NCT IDNCT03918070

SponsorTranslumina GmbH

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2024-04-24

View on ClinicalTrials.gov More Coronaropathy trials